C030370 | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | "2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of QKI mRNA" | 20206263 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
D001151 | Arsenic | Arsenic affects the methylation of QKI gene | 25304211 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of QKI mRNA | 20458559 |
D001280 | Atrazine | Atrazine results in decreased expression of QKI mRNA | 25929836 |
D001280 | Atrazine | Atrazine results in increased expression of QKI mRNA | 22378314 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of QKI mRNA | 20064835 |
D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of QKI mRNA | 19619570 |
D004958 | Estradiol | Estradiol results in decreased expression of QKI mRNA | 19619570 |
D004958 | Estradiol | [Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of QKI mRNA | 21185374 |
C006780 | bisphenol A | bisphenol A affects the expression of QKI mRNA | 25181051 |
C018475 | butyraldehyde | butyraldehyde results in decreased expression of QKI mRNA | 26079696 |
D002104 | Cadmium | Cadmium results in decreased expression of QKI mRNA | 23369406 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of QKI mRNA | 26472689 |
C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of QKI mRNA | 19320972 |
D003300 | Copper | [NSC 689534 binds to Copper] which results in increased expression of QKI mRNA | 20971185 |
D019327 | Copper Sulfate | Copper Sulfate results in increased expression of QKI mRNA | 19549813 |
C029892 | cupric chloride | cupric chloride results in increased expression of QKI mRNA | 17211630 |
D002945 | Cisplatin | Cisplatin results in decreased expression of QKI mRNA | 21151649 |
D004237 | Diuron | Diuron results in increased expression of QKI mRNA | 21551480 |
D004317 | Doxorubicin | QKI protein affects the susceptibility to Doxorubicin | 16217747 |
D004791 | Enzyme Inhibitors | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of QKI protein | 23301498 |
D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in decreased expression of QKI mRNA | 23649840 |
D005557 | Formaldehyde | Formaldehyde results in decreased expression of QKI mRNA | 23649840 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of QKI mRNA | 20655997 |
D006220 | Haloperidol | Haloperidol results in increased expression of QKI mRNA alternative form | 19335891 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of QKI mRNA | 23649840 |
C008493 | methylselenic acid | methylselenic acid results in increased expression of QKI mRNA | 18548127 |
C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in increased expression of QKI mRNA | 20971185 |
D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of QKI mRNA | 23557933 |
D020849 | Raloxifene Hydrochloride | [Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of QKI mRNA | 21185374 |
D015474 | Isotretinoin | Isotretinoin results in increased expression of QKI mRNA | 20436886 |
D013629 | Tamoxifen | Tamoxifen affects the expression of QKI mRNA | 14699072 |
D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of QKI mRNA | 19619570 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of QKI mRNA | 22298810 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of QKI mRNA | 19619570 |
D019772 | Topotecan | QKI protein affects the susceptibility to Topotecan | 16217747 |
D014212 | Tretinoin | Tretinoin results in decreased expression of QKI mRNA | 21934132 |
C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
C012589 | trichostatin A | trichostatin A results in decreased expression of QKI mRNA | 24935251 |
C012589 | trichostatin A | trichostatin A results in increased expression of QKI mRNA | 24935251|2627250 |
C057693 | troglitazone | troglitazone results in decreased expression of QKI mRNA | 28973697 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of QKI mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of QKI mRNA | 23179753|2493525 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of QKI mRNA | 23179753|2627250 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of QKI gene | 29154799 |
C025643 | vinclozolin | vinclozolin affects the expression of QKI mRNA | 19015723 |